We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReneuron Share News (RENE)

  • This share is currently suspended. It was suspended at a price of 3.275

Share Price Information for Reneuron (RENE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.275
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3.275
RENE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EXECUTIVE CHANGES: Long-serving Hansard and Northbridge CEOs retire

Fri, 12th Mar 2021 15:39

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Friday and not separately reported by Alliance News:

----------

Hansard Global PLC - Isle of Man-based specialist long-term savings provider - Gordon Marr to retire by the end of 2021 after 8 years as chief executive officer and 30 years with the company. Has initiated a search for a new CEO. "I have decided to announce my retirement plans now, providing ample time to identify a successor and ensure a smooth transition," Marr says. "I am committed to leading the company in the meantime, as we remain resolutely focused on delivering a solid performance in 2021, while positioning the company for further success in the future."

----------

Northbridge Industrial Services PLC - Burton on Trent, England-based firm that hires and sells specialist industrial equipment - CEO & Founder Eric Hook will step down from the board on March 31 after 15 years in post but remain as an advisor and significant shareholder. Chair Peter Harris will become executive chair with the directors of Northbridge's two divisions - Chris Caldwell of Crestchic and Ian Gardner of Tasman - reporting to him. Additionally Caldwell will be promoted to the board. Non-Executive Director Stephen Yapp is promoted to senior independent director, while Ash Mehta will step down as non-executive director.

----------

ReNeuron Group PLC - Bridgend, Wales-headquartered cell-based therapeutics - Chief Financial Officer Michael Hung resigns on Thursday "in order to pursue other projects", having joined the board in early 2001. Hung will remain until the end of May, and ReNeuron have started a search for his replacement.

----------

Anpario PLC - Nottinghamshire-based sustainable animal feed additives - Hires Ian Hamilton as non-executive director, starting April 1. Hamilton was in the founding management team of poultry breeding business Aviagen. He currently is non-executive chair of Horizon Proteins Ltd, which provides sustainable proteins for aquaculture recycled from the whiskey-making process, and of Biotangents Ltd, a veterinary diagnostics business.

----------

Gooch & Housego PLC - Ilminster, Somerset-based maker of optical components - Hires Jim Haynes as non-executive director, starting Friday. Haynes was executive vice president of operations at US optical components firm Oclaro Inc, which was bought by Lumentum Holdings Inc at the end of 2018.

----------

Universe Group PLC - Southampton, Hampshire-based retail management, payment and loyalty systems - Hires Neil Radley as CEO, joining Universe Group on May 1. Most recently, Radley led Jaja Finance Ltd, a fintech lending firm. He also has worked at Barclaycard, HBOS PLC and Bank One International. Radley replaces Jeremy Lewis, who the company last month said will leave on April 30 "to pursue other opportunities outside of the public markets", after seven years with Universe.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
5 Jul 2018 16:01

UK Earnings, Trading Statements Calendar - Next 7 Days

Friday 6 July SVM UK Emerging FundFull Year Results Monday 9 July GroupHalf

Read more
19 Apr 2018 13:17

ReNeuron Wins GBP1.5 Million Grant For Stem Cell Therapy Development

LONDON (Alliance News) - ReNeuron Group PLC on Thursday said it is the "lead" industry participant in a new GBP1.5 million grant from the UK's innovation agency Innovate grant has to

Read more
3 Apr 2018 13:29

Portugal looks to renewables as March output tops mainland power demand

LISBON, April 3 (Reuters) - For the first time in at least four decades, Portugal's monthly renewable energy production in March exceeded power demand

Read more
26 Mar 2018 15:53

ReNeuron Now Expects hRPC Stem Cell Trial Data In First Half Of 2019

LONDON (Alliance News) - ReNeuron Group PLC on Monday said it has decided to adjust the number of clinical sites for its CTX stem cell therapy candidate study, and now expects

Read more
5 Dec 2016 11:06

ReNeuron's first half revenues supported by new drug developments

(ShareCast News) - ReNeuron, an AIM-listed UK based developer of cell-based therapeutics, saw first half revenues double due to a series of successful drug trials. Revenues were £22,000 for the six months ended 30 September 2016 up from £11,000 in the first half of 2015. During the period, the grou

Read more
4 Dec 2016 14:45

Sunday share tips: ReNeuron, Clipper Logistics, RM Secured Direct Lending

(ShareCast News) - Shares of ReNeuron are for brave investors only, said the Sunday Times' Inside the City column. The stem cell pioneer is scheduled to publish the results of second-phase clinical trials of its potential stroke paralysis treatment alongside its interim results on Monday. ReNeuron's

Read more
6 Sep 2016 11:38

ReNeuron reports positive progress in clinical trials

(ShareCast News) - UK-based developer of cell-based therapeutics ReNeuron Group provided a trading update ahead of its annual general meeting on Tuesday. The AIM-traded firm reported that all patients have been treated in the PISCES II Phase II clinical trial of its CTX cell therapy candidate for pa

Read more
7 Jul 2016 09:37

ReNeuron Annual Loss Widens As Product Trials Ramp Up

Read more
4 Jul 2016 15:16

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
13 Jun 2016 07:58

ReNeuron Completes Phase II Stroke Therapy Trial Patient Recruitment

Read more
9 Jun 2016 08:55

ReNeuron Selects Glioblastoma Multiforme As First Clinical Target

Read more
8 Jun 2016 08:36

ReNeuron Progressing Blindness Candidate Through Phase I/II Trial

Read more
15 Mar 2016 09:52

ReNeuron Says First Patient Treated For Retinitis Pigmentosa

Read more
23 Feb 2016 16:05

ReNeuron moving to purpose-built labs in Wales

(ShareCast News) - ReNeuron's office, laboratory and manufacturing staff were preparing for a space upgrade this week, with the firm announcing it was moving from Guildford to Pencoed in South Wales. The AIM-traded stem cell therapy development company said the new location was purpose-built, and wo

Read more
23 Feb 2016 09:16

ReNeuron Relocating Headquarters To South Wales Business Park

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.